Remdesivir Gilead
“This Isn’t Healthcare, It’s Extortion”

Public Outcry Follows Gilead Decision to Charge $3000 for COVID Drug that Costs Pennies to Produce

To make matter worse, Remdesivir is a drug that “has had its development costs paid for, in large part, by independent donors like governments and ministries of health in China, the WHO, and the US government.”